Y Shiokawa

Discovery of 6-Oxo-3-(2-phenylpyrazolo[1,5-<i>a</i>]pyridin-3-yl)-1(6<i>H</i>)-pyridazinebutanoic Acid (FK 838):  A Novel Non-Xanthine Adenosine A₁Receptor Antagonist with Potent Diuretic Activity

Atsushi Akahane, Hirohito Katayama, Takafumi Mitsunaga et al. · Journal of Medicinal Chemistry · 1999 · 102 citations · Full text

A multicenter double blind controlled study of lipo-PGE1, PGE1 incorporated in lipid microspheres, in peripheral vascular disease secondary to connective tissue disorders.

Yutaka Mizushima, Y Shiokawa, Masato Homma et al. · PubMed · 1987 · 77 citations

Vascular Disease, Pathology, Multicenter Double Blind +19

Discovery of FK453, a novel non-xanthine adenosine A1 receptor antagonist

Atsushi Akahane, Hirohito Katayama, Takafumi Mitsunaga et al. · Bioorganic & Medicinal Chemistry Letters · 1996 · 28 citations

Molecular Pharmacology, Biochemistry, G Protein-coupled Receptor +9

Metabolism of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs

Shigeyuki Terashita, Yoji Tokuma, T. Fujiwara et al. · Xenobiotica · 1987 · 28 citations

A novel non-xanthine adenosine A1 receptor antagonist

Takao Terai, Yasuhiro Kita, Takahiro Kusunoki et al. · European Journal of Pharmacology · 1995 · 23 citations

Functional Selectivity, Medicine, Physiology +5